[Psychopharmacotherapy of anxiety, obsessive-compulsive and sleep disorders during pregnancy and lactation].
The aim of the third part of our work, associated with psychopharmacotherapy during pregnancy and lactation is to present guidelines of expert--groups concerning the current rules of treating anxiety, obsessive--compulsive and sleep disorders and actual data about spreading of these disorders, pre- and perinatal effects of drugs used and the classification of them according to FDA and the safety of these medications for the breast fed newborn.
Szajer
Katarzynar
K
Klinika Psychiatrii AM, Lublinie.
Karakuła
Hanna
H
Pawezka
Justyna
J
Grzywa
Anna
A
Przywara
Grzegorz
G
Gut
Adam
A
D001007:Anxiety / Q000188:drug therapy*; D001942:Breast Feeding; D005260:Female; D047109:Fetal Development / Q000187:drug effects*; D006801:Humans; D007229:Infant Welfare; D007231:Infant, Newborn; D007774:Lactation / Q000187:drug effects*; D008429:Maternal Welfare; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000523:psychology; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D012893:Sleep Wake Disorders / Q000188:drug therapy*
D011619:Psychotropic Drugs